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Purpose: To determine the association of increased NT with varies anomalies in the 1st tri-
mester by 4D ultrasound.
Patient and methods: Two hundred selected women with viable pregnancies were recruited
in this prospective study. All underwent 4D ultrasound at 11–14 completed weeks of ges-
tation for NT measurement. They were classified into 3 groups according to NT thickness:
Group I NT < 3.5 mm, group II NT between 3.5 and 4.4 mm and group III NT > 4.4 mm.
Statistical analysis was done using Chi-square test for qualitative data between the three
groups with significant correlation at p value 6 0.05.
Results: Out of 200 pregnant women, 30 was missed follow-up while 159 live birth and 11
pregnancies were terminated by abortion postnatal (n = 2), spontaneous (n = 3) or artificial
(n = 6). The highest median maternal age and fetal gestational age were found in group I.
The higher frequencies of congenital anomalies were found in fetuses with NT 3.5–
4.4 mm and P4.5 mm. The most common heart defect anomalies were VSD (13 fetuses);
retro-gnathia was found in 13 fetuses and hydronephrosis in 12 fetuses.
Conclusion: 4D ultrasound measurement of NT is of utmost importance in evaluation of
increased NT and associated fetal anomalies.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Increased nuchal translucency (NT) is associated with a
spectrum of fetal abnormalities. It can help us identify the
high-risk fetuses for trisomy 21 and other chromosomal
abnormalities. The commonest association is with chromo-
somal defects [1]. The association between increased
nuchal translucency and different chromosomal aneuploi-
dies was proved by several reports. It has been observedthat, in normal fetuses NT thickness increased with fetal
crown rump length (CRL) [2].
Recently, screening for chromosomal abnormalities is
increasingly done in the first trimester. The perceived
advantages of such first trimester diagnosis include a
decrease in surgical and psychiatric morbidity by allowing
option of an early versus late termination of pregnancy [3].
First-trimester ultrasound offers the advantages of
identifying and measuring small subcutaneous collections
of fluid behind the fetal back and neck. The size of the NT
increases with gestational age and fetal crown rump length
[3–5]. The translucent area disappears after 14 weeks ges-
tational age, when the subcutaneous tissue becomes more
echogenic. Advantages of first-trimester screening let us to
learn the baby’s risk for chromosomal problems relatively
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riage from an invasive test like chorionic villous sampling
(CVS) [3].
Like other screening tests, an NT scan will not give a
diagnosis, but the scan can assess the baby’s risk for certain
problems and help decide whether to have chorionic villus
sampling (CVS) or amniocentesis to find out whether the
baby is actually affected or not [6].
Several studies have also shown that in euploid fetuses
with increased NT thickness, the risk of congenital heart
defects, other structural anomalies and fetal death is
increased [7,8].
The aim of this work was to determine the association
of increased NT with varies anomalies on the 1st trimester
of pregnancy by 4D ultrasound evaluation.
2. Patients and methods
Two hundred selected women with viable pregnancies
were recruited in this prospective study, and all these
pregnant women were attending the prenatal diagnosis
at the radiology department in our institution between
March 2015 and March 2016 at 11–14 completed weeks
of gestation for NT measurement. They were included in
our study after approval of the local ethics committee. An
informed oral consent from each woman given before
enrollment into the study was taken.
2.1. Inclusion criteria
The mean maternal age was 34 (range, 20–46) years.
2.2. Exclusion criteria
The exclusion criteria were the loss to follow-up, the
chromosomal abnormalities or no information on kary-
otype in a fetal loss.Fig. 1. Represents the technique of 4D ultrasound: Firstly we adjust the scannin
Show the transverse and frontal sections, respectively, of the fetus and allow cont
in abnormal cases. (E) - Represents the surface reconstruction of a fetus with in
echogenic line (arrow).The cases were classified into 3 groups according to NT
thickness
I- Group NT < 3.5 mm
II- Group NT between 3.5 and 4.4 mm
III- Group NT > 4.4 mm
2.3. Technique of examination
US examination was done using ESAOTE, My lab 40 X
vision, Milan, Italy with 3.4 MHz on 2D probe and
5–9 MHz on 4D probe. 4D US examination was done by
2 consultant radiologists in consensus with 10 years of
experience in performing 4D ultrasound examination.2.4. Demographic details and ultrasound findings including
– We introduce the name of the patient, date and time of
examination into specially developed software and
store them.
– Then after telling the patient about the procedure
details, we use the 2D ultrasound to evaluate the fetal
viability, position and anatomy as well as measure the
CRL and NT. We use also the 2D ultrasound high resolu-
tion colored view to accurately estimate the previously
reported data.
– The NT is the maximum distance from the inner aspect
of the skin to the soft tissue over the cervical spine. It
should be measured in the sagittal view when the fetus
is in a neutral position. We measure the NT many times
(preferably three times) and the thickest one is
recorded.
– Then we shifted to the 4D probe to evaluate the fetus
for any congenital anomalies and accurately measure
the NT.g plane to obtain the true mid-sagittal section of the fetus as on (A–C) -
rol of the adjustment. (D) - A surface reconstruction of the fetus was done
creased NT thickness. The nuchal skin surface can be clearly seen as an
Table 1
Outcome of 170 pregnancies in 3 NT groups.
NT thickness Outcome
N Live birth Abortion Missed cases
Death after birth Spontaneous Artificial
<3.5 mm 46 44 – 1 1 11
3.5–4.4 mm 57 54 – 1 2 13
P4.5 mm 67 61 2 1 3 6
Total 170 159 2 3 6 30
100% 93.52% 1.17% 1.76% 3.53% 15%
Table 2
The median maternal age, newborn weight, gestational age at birth and sex distribution in different groups.
Age Group I Group II Group III
Maternal age 31.2 30.1 29.2
Newborn weight 3502 3325 3254
Gest. Age at birth 39.4 Ws 38.6 Ws 38.4 Ws
Sex XX XY XX XY XX XY
22 24 33 24 31 36
22
Table 3
The outcome of anomalies in different NT groups respectively.
NT thickness N Anomalies
Isolated Multiplex Without anomalies
Minor Major Minor Major P value
<3.5 mm 44 11 2 2 1 28 0.23
3.5–4.4 mm 56 12 3 2 7 32 0.03*
P4.5 mm 70 12 7 1 10 40 0.01*
170 35 12 5 18 100 0.02*
* Significant difference was set at p value 60.05.
Table 4
Clinical findings in live born infants with respect to the NT thickness.
Disorder n NT range
Heart defect 25
VSD 13 2.9–4.2 mm
VSD, ASD and aortic coarctation 5 3.3–4.2
Hypoplastic left ventricle 4 1.6–3.6
Isolated valve anomaly 3 1.9–3.7
Other Anomalies 64
Hydronephrosis 12 2.2–3.9
Cleft lip and/or cleft palate 3 2.9–4.4
Soft tissue edema 5 3.6–4.2
Nasal bone defect 4 1.6–3.8
Maxilla anomaly 3 3.1–4.1
Low set ear 8 3.4–4.9
Retro-gnathia 13 2.6–4.6
Hydropsfetalis 10 1.6–3.9
LL anomalies 12 2.8–3.7
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mid-sagittal section, the ultrasound probe should be
kept and the volume mode switched on to display
the 4D data. Here, we evaluate the NT by using the
multiplanar mode on the three orthogonal planes. If
there are fetal abnormalities detected, we do fetal
surface reconstruction and accurately estimate the
NT.
– At the end of the examination, we enter CRL and NT
thickness with the above stored data into an electronic
database (PIA, Fetal Database version 3.23, View Point,
Munich, Germany) and calculate the risk for trisomy 21.
– All the recoded above data should be stored on a rewri-
table magneto-optical disc.
2.5. We measure the NT by 4D ultrasound as follows: (Fig. 1)
o Firstly, we adjust the exact mid-sagittal section of the
fetus by fixing the three-axial center of rotation to the
central part of the nuchal region.
o Then the transverse and frontal sections of the fetus
showed and help for fine control of the adjustment.2.6. Image interpretation
Images were evaluated by 2 radiologists in consensus
with 10 years post fellowship experience in performing
obstetric 4D US.
Fig. 2. Female patient 40-year-old G 4 P3+1 with no history of consanguinity, was admitted for evaluation of the fetus in view of polyhydramnios. A- Shows
increased NT by 2D ultrasound. B- The nose is seen broad and flat on high resolution focused 2D ultrasound. C and D- The fetal nose is seen flat and his ear
seen low set by 4D image (arrow). E and F- Cardiac anomalies are seen in form of increased cardiothoracic ratio, enlarged Rt. atrium and presence of
pericardial effusion (small arrows). G- Chromosomal analysis of the same fetus revealed translocation affecting chromosome number 21(arrow).
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Fig. 3. Female patient 39 year-old G6 P4+1 with history of hypertension, was admitted for fetal evaluation. Patient’s obstetric history of TORSH infection is
established A- Shows increased NT measured by high resolution focused 2D ultrasound (7 mm). B- Shows increased AC in comparison with BPD and HC by
4D ultrasound. C and D- Show retro-gnathia (white arrow). E- Shows echogenic bowels (thick short arrow). F- Shows ascites (long arrow). G- Shows pleural
effusion (short arrow). H- Shows post labor image of the fetus.
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Fig. 4. Female patient 36 year-old G5 P4+0 with no history of Down’s syndrome, was admitted for fetal evaluation. A- Shows facial anomalies in form of
abnormal nasal bone (long white arrow) and retro-gnathia (short arrow) in a 4D image. B- Shows A-V canal defect. C- Shows post labor image of the fetus.
D- Shows chromosomal analysis of the same fetus which revealed translocation affecting chromosome number 21(arrow).
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– The associated congenital anomalies found by 4 D
assessment in association with increased NT will be cal-
culated using Chi-square test for qualitative data
between the three groups with the significant correla-
tion was set at p value 60.05.3. Results
Out of 200 pregnant women, 30 was missed to follow-
up while the number of live birth was 159 and 11 pregnan-
cies were terminated by abortion either spontaneous
(n = 3), artificial (n = 6) or death after birth (n = 2) (Table 1).
The fetuses had an average CRL of 64.3 mm, ranging
from 45 to 84 mm.
The highest median maternal age and fetal gestational
age were found in group I (Table 2).
The higher frequencies of congenital anomalies were
found in fetuses with NT 3.5–4.4 mm and P4.5 mm, 24
out of 56 and 30 out of 70 fetuses respectively with
42.8% for each. We found also, the most commonmultiplex
major anomalies when the NT was more than 4.4 mm, as
well as the isolated minor anomalies. On the other handthe least common anomalies were detected when the NT
thickness was less than 3.5 mm (Table 3).
There was significant correlation between NT and inci-
dence of congenital anomalies in group II (P value < 0.03)
and group III (P value < 0.01) and overall (P value 0.02)
(Table 3).
The most common heart defect anomalies was VSD (13
fetuses), while retro-gnathia was found in 13 fetuses and
hydronephrosis in 12 fetuses (Table 4).
Many cases with variable encountered congenital
anomalies associated with increased NT thickness are rep-
resented in Figs. 2–5.4. Discussion
It was reported that an increase in NT is considered a
useful marker of chromosomal abnormalities, fetal malfor-
mations and genetic syndromes. Consequently, the risk of
adverse pregnancy outcome is proportional to the degree
of NT enlargement, Bilardo et al. [9].
In this study, we evaluated the pregnancy outcome of a
group of 170 fetuses with measurement of NT thickness.
We found that the fetal loss rate reached 6.4% (11 fetuses
were aborted either spontaneous in 3 fetuses, artificial
Fig. 5. Female patient 29 year-old G4 P3+1 with no history of consanguinity or Down syndrome was admitted for fetal evaluation. A and B- Show increased
NT measured by 2D ultrasound in (A) and 4D ultrasound on (B). C- Shows absent nasal bone (small arrows). D- No blood flow detected within the thickened
cord.
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fetuses). In a study done by Ksenija et al. [10] it was found
that the overall fetal loss reached 7%. Also, in a study done
by Westin et al. [11] it was concluded that fetal termina-
tion ranged from 2.3 to 16.9%.
Regarding the 159 live birth fetuses, 44 fetuses have NT
less than 3.5 mm, while 54 have NT from 3.5 to 4.4 mm
and 61 fetuses have NT more than 4.4 mm. Among the lost
pregnancies (11 fetuses), 2 of them (4.5%) had NT less than
3.5 mm (1 spontaneous abortion and the other artificial
abortion), 3 of them had NT from 3.5 to 4.4 mm (5.5%) (1
spontaneous and the other 2 artificial abortion), and 6
fetuses had NT more than 4.4 mm (9.5%) (1 spontaneous
abortion, 2 artificial abortions and 2 fetuses died after
birth). So, we conclude that the incidence of fetal loss
(abortion) increased when the NT thickness increased.
These data were also proposed on a study done by Said
et al., Axt-Fliedner et al. and Markov et al. [12,7,8].
In our research, maternal age was found lower in the
3rd group and proved by study done by Szabo et al. [4], this
can be explained by the fact that in the 1st two groups,
maternal age played an important role in the calculation
of anomaly risk and so the parents can accept the prenatal
invasive test.
Regarding our studied 170 pregnancies; 100 pregnan-
cies have no anomaly while 70 pregnancies have different
anomalies with an incidence of 41%. The higher incidence
of fetal anomaly was detected among NT 3.5–4.4 mm(significant P value 0.03) and on more than 4.4 mm rep-
resenting 42.8% of the encountered anomalies (significant
P value 0.01). Also, there was significant correlation
between NT and incidence of congenital anomalies in
groups II and III and overall. This was also proved by
Graesslin et al. [13], who stated that the frequency of con-
genital fetal anomalies increased when the NT thickness
increased.
In this study, the congenital cardiac defects are the most
common anomalies representing 35.7% of all anomalies
and detected in 25/70 pregnancies. This percentage is
higher than the outcome in other studies like those done
by Evans et al. and Orosz et al. [14,15] who stated that
the incidence of cardiac anomalies reached 14.3–22.4%,
and this may be explained by difference in sample size
and NT method of measurement.
We have 25 cardiac anomalies detected in this study,
including ventricular septal defect in 13/25, complex heart
anomaly (VSD, ASD and aortic knuckle) present in 5/25
anomaly, hypoplastic Lt. ventricle in 4/25 and isolated
valve anomaly detected on 3/25. Souka et al. and Burns
et al. [16,17] proved that, the frequency of congenital heart
defects increased from 11% when the NT 3.5–4.4 mm and
reached to 17.3% when the NT was more than 4.4 mm.
Most of CHD in our study occurred with NT less than
4.4 mm and this is in contrary to Clur et al. [18] who found
that the frequency of congenital heart defects increased
when the NT thickness was more than 4.5 mm.
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lies, hydronephrosis was found in 12 out of 64 anomalies,
cleft lip and palate detected in 3/64 fetuses, soft tissue
edema in 5/64, nasal bone defect in 4/64, maxillary anom-
aly in 3/64, hydrops-fetalis in 10/64 and lower limb
anomalies in 12/64 anomaly. In a study done by Ksenija
et al. [10] it was found that the 2nd most common isolated
anomaly was the hydronephrosis followed by cleft lip and/
or palate. A study done by Cicero et al. [19], reported that
out of 701 fetuses with increased NT a nasal bone could
not be visualized in 73% of Down syndrome (43/59) and
could not be visualized in 0.5% of unaffected fetuses
3/603, while Hutchon et al. [20] described a series of 5
cases of Down syndrome with clearly visible nasal bones.
Markov et al. [21] considered a direct relationship
between increased NT and the occurrence of facial cleft.
Geipel et al. [22] stated an increased relationship between
the increased NT measurements and the development of
hydrops-fetalis and all those are corresponding to our
research results.5. Conclusion
4D ultrasound measurement of NT is of utmost impor-
tance as NT more than 3.5 mm should be considered a
cutoff value and needs further investigations by serum
markers. Increased NT is associated with a spectrum of
fetal anomalies; the commonest of them is chromosomal
cardiac defects. A study on a large number of pregnancies
with long duration of follow-up is recommended to estab-
lish guidelines for objective parental counseling.Funding
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